ClinConnect ClinConnect Logo
Search / Trial NCT06505720

Use of Arthroscopy in Treatment of Acute Pediatric Septic Hip Infection

Launched by HESHAM MOHAMED ELBASEET · Jul 11, 2024

Trial Information

Current as of August 21, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is exploring the use of a procedure called hip arthroscopy to treat acute septic hip infections in children. An acute septic hip infection is a serious condition where the hip joint becomes infected, which can be very painful and requires quick medical attention. Currently, the standard treatment involves a more invasive surgery to clean out the infection. This trial aims to compare the effectiveness of hip arthroscopy, a less invasive method that has been used for over 30 years, with the traditional surgery to see which approach works better for children.

To be eligible for this study, children between the ages of 10 months and 14 years who have either one or both hips affected by this infection can participate. However, children with other hip problems or those whose parents do not wish to take part will not be included. Participants can expect to receive either treatment while being carefully monitored by the medical team. This study is important because it may help determine the best way to treat this urgent condition in young patients, potentially leading to better outcomes and quicker recoveries.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age 10 months - 14 years _unilateral or bilateral acute septic hip arthritis
  • Exclusion Criteria:
  • Children with pre-existing other pathology of the affected hip, whether he / she has surgery for management of this pathology or not.
  • Patients whose parents refuse to participate in the study

About Hesham Mohamed Elbaseet

Hesham Mohamed Elbaseet is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With a focus on innovative therapies and evidence-based practices, Elbaseet oversees a diverse portfolio of clinical trials that aim to address unmet medical needs across various therapeutic areas. His expertise in protocol development, regulatory compliance, and stakeholder engagement ensures the efficient execution of trials while maintaining the highest ethical standards. Elbaseet's collaborative approach fosters partnerships with research institutions, healthcare professionals, and regulatory bodies, driving progress in the field of clinical research.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported